Sign In
Buy MACK
$15.13
+0 (+0%)
At Close: Aug 19, 2024
Merrimack Reports Second Quarter 2020 Financial Results
12:00am, Friday, 07'th Aug 2020
Merrimack Reports Second Quarter 2020 Financial Results
We Think Merrimack Pharmaceuticals (NASDAQ:MACK) Needs To Drive Business Growth Carefully
12:33pm, Wednesday, 05'th Aug 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Insider Sells $363,326.04 in Stock
04:44am, Monday, 27'th Jul 2020
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) insider Gary L. Crocker sold 117,963 shares of Merrimack Pharmaceuticals stock in a transaction that occurred on Wednesday, July 22nd. The shares were sold
Contrasting Merrimack Pharmaceuticals (NASDAQ:MACK) and Ardelyx (NASDAQ:ARDX)
03:10am, Sunday, 14'th Jun 2020
Merrimack Pharmaceuticals (NASDAQ:MACK) and Ardelyx (NASDAQ:ARDX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of th
Merrimack Pharmaceuticals Yesterday Reported Q1 EPS $0.020 Up From $(0.780) YoY
02:48pm, Friday, 08'th May 2020Merrimack Reports First Quarter 2020 Financial Results
10:10pm, Thursday, 07'th May 2020
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its first quarter 2020 financial results for the period ended March 31, 2020.
Merrimack Reports First Quarter 2020 Financial Results
12:00am, Thursday, 07'th May 2020
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its first quarter 2020 financial results for the period ended March 31, 2020.
US Stock Market Weekly Update March 30- April 3, 2020
03:03pm, Sunday, 05'th Apr 2020
For the week ending on April 3, the US stock market declined and all major stock indexes had losses. We had a negative figure for the US non-far payrolls and the weekly US jobless claims, showing the
Merrimack Pharma Reports Receipt Of $2.25M Related To Closing Of Asset Sale For Preclinical Nanoliposome Programs To Celator Pharma
12:44pm, Thursday, 02'nd Apr 2020Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update
12:30pm, Thursday, 02'nd Apr 2020
Merrimack Announces Sale Of Early Stage Asset for $2.25 Million And Provides Strategy Update.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASD
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
Stocks That Hit 52-Week Lows On Thursday
02:49pm, Thursday, 19'th Mar 2020
On Thursday morning, 1178 companies hit new 52-week lows.
Facts of Interest:
The largest company by market cap to set a new 52-week low was Nuveen Preferred & Income...
